FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.

Awarded to SYNTHEGO CORPORATION

PIID 75N92021P00258US · USAspendingOther
$86.8K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$86,750sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateAug 2, 2021
Company legal name
SYNTHEGO CORPORATION
UEI / CAGE
RNDBNJAKTJC9 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Other
NAICS
541714
PSC
R499
Performance period
Not reported — Not reported
Recipient address
3696A HAVEN AVE, REDWOOD CITY, SAN MATEO, CA, 94063
Place of performance
REDWOOD CITY, SAN MATEO, CA, 94063
Source last modified
Nov 3, 2026

Description

TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.

    US · usaspendingSource ↗
  2. Value increased

    TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.

    US · usaspending$86.8KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Jul 29, 20210Not reported$86,750.00Not reportedNot reportedTO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.USAspending ↗